Brett A. Giffin, Chief Commercial Officer at T2 Biosystems, Inc. (TTOO), sold 537 shares at $0.65 ($349) on 2023-02-20, disclosed to the SEC on 2023-11-28.
Scheduled sale ($349) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TTOO | BUY | 2022-04-11 | $5K | — | Filing → |